|
1
|
Xu FX, Zhang YL, Liu JJ, Zhang DD and Chen
HB: Hypoxic markers in non-small cell lung cancer (NSCLC)-A review.
Eur Rev Med Pharmacol Sci. 20:849–852. 2016.PubMed/NCBI
|
|
2
|
Hung WY, Chang JH, Cheng Y, Chen CK, Chen
JQ, Hua KT, Cheng CW, Hsiao M, Chung CL, Lee WJ and Chien MH:
Leukocyte cell-derived chemotaxin 2 retards non-small cell lung
cancer progression through antagonizing MET and EGFR activities.
Cell Physiol Biochem. 51:337–355. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang P, Lv HY, Zhou DM and Zhang EN:
miR-204 suppresses non-small-cell lung carcinoma (NSCLC) invasion
and migration by targeting JAK2. Genet Mol Res. 15:2016.doi:
10.4238/gmr.15026415.
|
|
4
|
Brueckl WM, Achenbach HJ, Ficker JH and
Schuette W: Erlotinib treatment after platinum-based therapy in
elderly patients with non-small-cell lung cancer in routine
clinical practice-results from the ElderTac study. BMC Cancer.
18:3332018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tata PR, Chow RD, Saladi SV, Tata A,
Konkimalla A, Bara A, Montoro D, Hariri LP, Shih AR, Mino-Kenudson
M, et al: Developmental history provides a roadmap for the
emergence of tumor plasticity. Dev Cell. 44:679–693.e5. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Subramanian M, McMurry T, Meyers BF, Puri
V and Kozower BD: Long-term results for clinical stage ia lung
cancer: Comparing lobectomy and sublobar resection. Ann Thorac
Surg. 106:375–381. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hirsch FR, Sequist LV, Gore I, Mooradian
M, Simon G, Croft EF, DeVincenzo D, Munley J, Stein D, Freivogel K,
et al: Long-term safety and survival with gefitinib in select
patients with advanced non-small cell lung cancer: Results from the
US IRESSA clinical access program (ICAP). Cancer. 124:2407–2414.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ren J, Jian F, Jiang H, Sun Y, Pan S, Gu
C, Chen X, Wang W, Ning G, Bian L and Sun Q: Decreased expression
of SFRP2 promotes development of the pituitary corticotroph adenoma
by upregulating Wnt signaling. Int J Oncol. 52:1934–1946.
2018.PubMed/NCBI
|
|
9
|
Xiao X, Xiao Y, Wen R, Zhang Y, Li X, Wang
H, Huang J, Liu J, Long T and Tang J: Promoting roles of the
secreted frizzled-related protein 2 as a Wnt agonist in lung cancer
cells. Oncol Rep. 34:2259–2266. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Suzuki M, Shigematsu H, Nakajima T, Kubo
R, Motohashi S, Sekine Y, Shibuya K, Iizasa T, Hiroshima K,
Nakatani Y, et al: Synchronous alterations of Wnt and epidermal
growth factor receptor signaling pathways through aberrant
methylation and mutation in non small cell lung cancer. Clin Cancer
Res. 13:6087–6092. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang X, Rong X, Chen Y and Su L:
Methylation-mediated loss of SFRP2 enhances invasiveness of
non-small cell lung cancer cells. Hum Exp Toxicol. 37:155–162.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wallace DC: Mitochondria and cancer. Nat
Rev Cancer. 12:685–698. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li W, Li Y, Siraj S, Jin H, Fan Y, Yang X,
Huang X, Wang X, Wang J, Liu L, et al: FUNDC1-mediated mitophagy
suppresses hepatocarcinogenesis by inhibition of inflammasome
activation. Hepatology. 69:604–621. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li H, He F, Zhao X, Zhang Y, Chu X, Hua C,
Qu Y, Duan Y and Ming L: YAP Inhibits the apoptosis and migration
of human rectal cancer cells via suppression of
JNK-Drp1-Mitochondrial Fission-HtrA2/Omi pathways. Cell Physiol
Biochem. 44:2073–2089. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang J, Zhang Y, Wu W, Wang F, Liu X,
Shui G and Nie C: Guanylate-binding protein 2 regulates
Drp1-mediated mitochondrial fission to suppress breast cancer cell
invasion. Cell Death Dis. 8:e31512017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nishimura A, Shimauchi T, Tanaka T,
Shimoda K, Toyama T, Kitajima N, Ishikawa T, Shindo N,
Numaga-Tomita T, Yasuda S, et al: Hypoxia-induced interaction of
filamin with Drp1 causes mitochondrial hyperfission-associated
myocardial senescence. Sci Signal. 11(pii): eaat51852018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baek SH, Park SJ, Jeong JI, Kim SH, Han J,
Kyung JW, Baik SH, Choi Y, Choi BY, Park JS, et al: Inhibition of
Drp1 ameliorates synaptic depression, abeta deposition, and
cognitive impairment in an alzheimer's disease model. J Neurosci.
37:5099–5110. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang X, Wang H, Ni HM, Xiong A, Wang Z,
Sesaki H, Ding WX and Yang L: Inhibition of Drp1 protects against
senecionine-induced mitochondria-mediated apoptosis in primary
hepatocytes and in mice. Redox Biol. 12:264–273. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang M, Wei R, Wang Y, Su T, Li P and
Chen X: The uremic toxin hippurate promotes endothelial dysfunction
via the activation of Drp1-mediated mitochondrial fission. Redox
Biol. 16:303–313. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang W, Liu K, Pei Y, Ma J, Tan J and
Zhao J: Mst1 regulates non-small cell lung cancer A549 cell
apoptosis by inducing mitochondrial damage via ROCK1/Factin
pathways. Int J Oncol. 53:2409–2422. 2018.PubMed/NCBI
|
|
21
|
Clevers H and Nusse R: Wnt/beta-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song Q, Gou WL and Zhang R: FAM3A
attenuates ER stress-induced mitochondrial dysfunction and
apoptosis via CHOP-Wnt pathway. Neurochem Int. 94:82–89. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brown K, Yang P, Salvador D, Kulikauskas
R, Ruohola-Baker H, Robitaille AM, Chien AJ, Moon RT and Sherwood
V: WNT/beta-catenin signaling regulates mitochondrial activity to
alter the oncogenic potential of melanoma in a PTEN-dependent
manner. Oncogene. 36:3119–3136. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Berger E, Rath E, Yuan D, Waldschmitt N,
Khaloian S, Allgäuer M, Staszewski O, Lobner EM, Schöttl T,
Giesbertz P, et al: Mitochondrial function controls intestinal
epithelial stemness and proliferation. Nat Commun. 7:131712016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen DQ, Cao G, Chen H, Liu D, Su W, Yu
XY, Vaziri ND, Liu XH, Bai X, Zhang L and Zhao YY: Gene and protein
expressions and metabolomics exhibit activated redox signaling and
wnt/beta-catenin pathway are associated with metabolite dysfunction
in patients with chronic kidney disease. Redox Biol. 12:505–521.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gao D and Chen HQ: Specific knockdown of
HOXB7 inhibits cutaneous squamous cell carcinoma cell migration and
invasion while inducing apoptosis via Wnt/β-catenin signaling
pathway. Am J Physiol Cell Physiol. 315:C675–C686. 2018. View Article : Google Scholar
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gao X, Zhang X, Hu J, Xu X, Zuo Y, Wang Y,
Ding J, Xu H and Zhu S: Aconitine induces apoptosis in H9c2 cardiac
cells via mitochondriamediated pathway. Mol Med Rep. 17:284–292.
2018.PubMed/NCBI
|
|
29
|
Zhu P, Hu S, Jin Q, Li D, Tian F, Toan S,
Li Y, Zhou H and Chen Y: Ripk3 promotes ER stress-induced
necroptosis in cardiac IR injury: A mechanism involving calcium
overload/XO/ROS/mPTP pathway. Redox Biol. 16:157–168. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ye H, Wang WG, Cao J and Hu XC: SPARCL1
suppresses cell migration and invasion in renal cell carcinoma. Mol
Med Rep. 16:7784–7790. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou H, Hu S, Jin Q, Shi C, Zhang Y, Zhu
P, Ma Q, Tian F and Chen Y: Mff-Dependent mitochondrial fission
contributes to the pathogenesis of cardiac microvasculature
ischemia/reperfusion injury via induction of mROS-mediated
cardiolipin oxidation and HK2/VDAC1 disassociation-involved mPTP
Opening. J Am Heart Assoc. 6(pii): e0053282017.PubMed/NCBI
|
|
32
|
Burke PJ: Mitochondria, bioenergetics and
apoptosis in cancer. Trends Cancer. 3:857–870. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jin Q, Li R, Hu N, Xin T, Zhu P, Hu S, Ma
S, Zhu H, Ren J and Zhou H: DUSP1 alleviates cardiac
ischemia/reperfusion injury by suppressing the Mff-required
mitochondrial fission and Bnip3-related mitophagy via the JNK
pathways. Redox Biol. 14:576–587. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Altieri DC: Mitochondrial dynamics and
metastasis. Cell Mol Life Sci. 76:827–835. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu S, Chen X, Chen R, Wang J, Zhu G,
Jiang J, Wang H, Duan S and Huang J: Diagnostic role of Wnt pathway
gene promoter methylation in non small cell lung cancer.
Oncotarget. 8:36354–36367. 2017.PubMed/NCBI
|
|
36
|
Yu Y, Xu L, Qi L, Wang C, Xu N, Liu S, Li
S, Tian H, Liu W, Xu Y and Li Z: ABT737 induces mitochondrial
pathway apoptosis and mitophagy by regulating DRP1-dependent
mitochondrial fission in human ovarian cancer cells. Biomed
Pharmacother. 96:22–29. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
De Paepe B, Lefever S and Mestdagh P: How
long noncoding RNAs enforce their will on mitochondrial activity:
Regulation of mitochondrial respiration, reactive oxygen species
production, apoptosis, and metabolic reprogramming in cancer. Curr
Genet. 64:163–172. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Weinberg SE, Sena LA and Chandel NS:
Mitochondria in the regulation of innate and adaptive immunity.
Immunity. 42:406–417. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Deng L, Gao X, Liu B, He X, Xu J, Qiang J,
Wu Q and Liu S: NMT1 inhibition modulates breast cancer progression
through stress-triggered JNK pathway. Cell Death Dis. 9:11432018.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Karsli-Uzunbas G, Guo JY, Price S, Teng X,
Laddha SV, Khor S, Kalaany NY, Jacks T, Chan CS, Rabinowitz JD and
White E: Autophagy is required for glucose homeostasis and lung
tumor maintenance. Cancer Discov. 4:914–927. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Satoh W, Matsuyama M, Takemura H, Aizawa S
and Shimono A: Sfrp1, Sfrp2, and Sfrp5 regulate the
Wnt/beta-catenin and the planar cell polarity pathways during early
trunk formation in mouse. Genesis. 46:92–103. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chung MT, Lai HC, Sytwu HK, Yan MD, Shih
YL, Chang CC, Yu MH, Liu HS, Chu DW and Lin YW: SFRP1 and SFRP2
suppress the transformation and invasion abilities of cervical
cancer cells through Wnt signal pathway. Gynecol Oncol.
112:646–653. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Singh S, Mishra A, Mohanbhai SJ, Tiwari V,
Chaturvedi RK, Khurana S and Shukla S: Axin-2 knockdown promote
mitochondrial biogenesis and dopaminergic neurogenesis by
regulating Wnt/beta-catenin signaling in rat model of Parkinson's
disease. Free Radic Biol Med. 129:73–87. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang TL, Ouyang CS and Lin LZ: β-Asarone
suppresses Wnt/β-catenin signaling to reduce viability, inhibit
migration/invasion/adhesion and induce mitochondria-related
apoptosis in lung cancer cells. Biomed Pharmacother. 106:821–830.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yunjiao W, Tang H, He G, Shi Y, Kang X,
Lyu J, Zhou M, Zhu M, Zhang J and Tang K: High concentration of
aspirin induces apoptosis in rat tendon stem cells via inhibition
of the Wnt/β-catenin pathway. Cell Physiol Biochem. 50:2046–2059.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhao H, Pan W, Chen L, Luo Y and Xu R:
Nur77 promotes cerebral ischemia-reperfusion injury via activating
INF2-mediated mitochondrial fragmentation. J Mol Histol.
49:599–613. 2018. View Article : Google Scholar : PubMed/NCBI
|
